medicament$47518$ - ορισμός. Τι είναι το medicament$47518$
Diclib.com
Λεξικό ChatGPT
Εισάγετε μια λέξη ή φράση σε οποιαδήποτε γλώσσα 👆
Γλώσσα:

Μετάφραση και ανάλυση λέξεων από την τεχνητή νοημοσύνη ChatGPT

Σε αυτήν τη σελίδα μπορείτε να λάβετε μια λεπτομερή ανάλυση μιας λέξης ή μιας φράσης, η οποία δημιουργήθηκε χρησιμοποιώντας το ChatGPT, την καλύτερη τεχνολογία τεχνητής νοημοσύνης μέχρι σήμερα:

  • πώς χρησιμοποιείται η λέξη
  • συχνότητα χρήσης
  • χρησιμοποιείται πιο συχνά στον προφορικό ή γραπτό λόγο
  • επιλογές μετάφρασης λέξεων
  • παραδείγματα χρήσης (πολλές φράσεις με μετάφραση)
  • ετυμολογία

Τι (ποιος) είναι medicament$47518$ - ορισμός

FRENCH PHARMACEUTICALS AND HEALTH CARE PRODUCTS COMPANY
Pierre Fabre Group; Pierre Fabre Medicament

Counterfeit medications         
  • Bulk bag of counterfeit [[Viagra]]
  • US FDA official inspects package suspected of containing counterfeit drugs at an international mail facility in New York
MEDICATION OR PHARMACEUTICAL ITEM WHICH IS PRODUCED AND SOLD WITH THE INTENT TO DECEPTIVELY REPRESENT ITS ORIGIN, AUTHENTICITY OR EFFECTIVENESS
Counterfeit drug; Counterfeit medicine; Counterfeit drugs; Counterfeit medicines; Fake drug; Fake drugs; Fake medicine; Fake medicines; Counterfeit pharmaceuticals; False medicine; False medicines; Fake medicament; Fake medicaments; False medicaments; False medicament; Fake medication; Fake medications; False medications; False medication; Counterfeit medication; Counterfeit medicament; Counterfeit medicaments
A counterfeit medication or a counterfeit drug is a medication or pharmaceutical item which is produced and sold with the intent to deceptively represent its origin, authenticity, or effectiveness. A counterfeit drug may contain inappropriate quantities of active ingredients, or none, may be improperly processed within the body (e.
Active ingredient         
BIOLOGICALLY ACTIVE COMPONENT OF A PRODUCT FORMULATION
Active Pharmaceutical Ingredient; Active pharmaceutical ingredient; Activeingred; Active pharmaceutical ingredients; Active substance; Active principle; Active ingredients; Pharmaca; Bulk active; Active constituent; Pharmacological agent; Pharmaceutically active compound; Active Pharmaceutical Ingredients
An active ingredient is any component that provides biologically active or other direct effect in the diagnosis, cure, mitigation, treatment, or prevention of disease or to affect the structure or any function of the body of humans or animals. The similar terms active pharmaceutical ingredient (also abbreviated as API) and bulk active are also used in medicine, and the term active substance may be used for natural products.
Drug-induced hyperthermia         
SYMPTOM
Iatrogenic fever; Drug induced fever; Drug fever; Drug-induced fevers; Drug-induced fever
Drug-induced fever is a symptom of an adverse drug reaction wherein the administration of drugs intended to help a patient causes a hypermetabolic state resulting in fever. The drug may interfere with heat dissipation peripherally, increase the rate of metabolism, evoke a cellular or humoral immune response, mimic endogenous pyrogen, or damage tissues.

Βικιπαίδεια

Laboratoires Pierre Fabre

Laboratoires Pierre Fabre is a French multinational pharmaceutical and cosmetics company. The company had a consolidated turnover of 1.978 billion euros in 2012 (including 54% international). It is headquartered in the city of Castres, Midi-Pyrénées, France.

Founded in 1962 by Pierre Fabre (1926-2013), the company is present in over 130 countries. Laboratories Pierre Fabre had approximately 10,000 employees in 2012, 33% of whom are internationally based, while the remaining 6,700 employees were based in France. The company's business activity is focused on research, development, manufacturing and marketing of cosmetics, prescription medicines and family health products. Pharmaceuticals and phytotherapy represent 47% of turnover, whereas cosmetics represent 53% (percentages of 2012 turnover).

Pierre Fabre is best known for its vinorelbine (Navelbine), an anticancer drug of the vinca alkaloid class. They also developed vinflunine, a fluorinated vinca alkaloid derivative available in Australia for "advanced or metastatic transitional cell carcinoma of the urothelial tract after failure of a prior platinum containing regimen."

Olivier Bohuon was Chief Executive from September 2010 to April 2011.